These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32843693)

  • 1. Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections.
    Tan CW; Wong WH; Cheen MHH; Chu YMH; Lim SS; Ng LCK; Yeo DGD; Morvil G; Lee LH; Ng HJ
    Sci Rep; 2020 Aug; 10(1):14186. PubMed ID: 32843693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A correlation of thrombin generation assay and clot waveform analysis in patients on warfarin.
    Cheong MA; Tan CW; Wong WH; Kong MC; See E; Yeang SH; Koh SK; Shim YT; Lee LH; Ng HJ
    Hematology; 2022 Dec; 27(1):337-342. PubMed ID: 35255239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated partial thromboplastin time-based clot waveform analysis: a potential for application in acute myocardial infarction and its complications.
    Ng CL; Uy FM; Cheong MA; Wong WH; Lau YH; Ng HJ; Yeo KK; Tan CW
    Sci Rep; 2024 Sep; 14(1):20917. PubMed ID: 39251656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated activated partial thromboplastin time-based clot waveform analysis markers have strong positive association with acute venous thromboembolism.
    Tan CW; Cheen MHH; Wong WH; Wu IQ; Chua BLW; Ahamedulla SH; Lee LH; Ng HJ
    Biochem Med (Zagreb); 2019 Jun; 29(2):020710. PubMed ID: 31223264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform Analysis.
    Kato K; Hatayama Y; Shimohiro H; Ichikawa H; Fukuda T
    Yonago Acta Med; 2022 Aug; 65(3):226-230. PubMed ID: 36061578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotational Thromboelastometry and Clot Waveform Analysis as Point-of-Care Tests for Diagnosis of Disseminated Intravascular Coagulation in Critically Ill Children in Thailand.
    Chanthong S; Choed-Amphai C; Manowong S; Tuntivate P; Tansriratanawong S; Makonkawkeyoon K; Natesirinilkul R
    Pediatr Crit Care Med; 2024 May; 25(5):e221-e231. PubMed ID: 38299935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.
    Dave RG; Geevar T; Mammen JJ; Vijayan R; Mahasampath G; Nair SC
    Indian J Pathol Microbiol; 2021; 64(1):117-122. PubMed ID: 33433420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A.
    Song G; Wang Y; Zhang L; Xia M
    Thromb Haemost; 2024 Sep; 124(9):852-860. PubMed ID: 38626899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19.
    Ichikawa J; Okazaki R; Fukuda T; Ono T; Ishikawa M; Komori M
    J Thromb Thrombolysis; 2022 Jan; 53(1):118-122. PubMed ID: 34263423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clot waveform analysis in acute promyelocytic leukemia.
    Terras M; El Borgi W; Betbout W; Jaied R; Lakhal FB; Salem SF; Ghali O; Gouider E
    Blood Coagul Fibrinolysis; 2024 Jan; 35(1):27-31. PubMed ID: 37994627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reagent Effects on the Activated Partial Thromboplastin Time Clot Waveform Analysis: A Multi-Centre Study.
    Wong WH; Tan CW; Abdul Khalid NB; Dalimoenthe NZ; Yip C; Tantanate C; Lim RD; Kim JH; Ng HJ
    Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation Status Using Clot Wave Analysis in Patients With Prolonged Immobilization.
    Iberahim S; Muhamat Yusoff R; Mohd Noor NH; Hassan R; Ramli NN; Bahar R; Zulkafli Z; Wan Ab Rahman WS; Ab Ghani AS
    Cureus; 2024 Jan; 16(1):e51483. PubMed ID: 38304638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal monitoring of bypass therapy in hemophilia A patients with inhibitors by the use of clot waveform analysis.
    Haku J; Nogami K; Matsumoto T; Ogiwara K; Shima M
    J Thromb Haemost; 2014; 12(3):355-62. PubMed ID: 24354697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis.
    Fan BE; Ng J; Chan SSW; Christopher D; Tso ACY; Ling LM; Young BE; Wong LJL; Sum CLL; Tan HT; Ang MK; Lim GH; Ong KH; Kuperan P; Chia YW
    J Thromb Thrombolysis; 2021 Apr; 51(3):663-674. PubMed ID: 33098540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A.
    Matsumoto T; Nogami K; Tabuchi Y; Yada K; Ogiwara K; Kurono H; Arai N; Shima M
    Haemophilia; 2017 Sep; 23(5):e427-e435. PubMed ID: 28750470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clot Waveform Analysis for Monitoring Hemostasis.
    Nogami K
    Semin Thromb Hemost; 2023 Sep; 49(6):592-599. PubMed ID: 36174610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study.
    Fan BE; Ramanathan K; Sum CLL; Christopher D; Chan SSW; Lim GH; Bok CF; Wong SW; Lye DC; Young BE; Lim JY; Lee RM; Lim SP; Tan HT; Ang MK; Lau SL; Kuperan P; Ong KH; Chia YW
    J Thromb Thrombolysis; 2022 Apr; 53(3):646-662. PubMed ID: 34581945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall hemostasis potential and aPTT-clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype.
    Milos M; Coen Herak D; Mahmoud Hourani Soutari N; Pavic J; Zupancic-Salek S; Zadro R; Antovic JP
    Int J Lab Hematol; 2021 Apr; 43(2):273-280. PubMed ID: 32964648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities.
    Tan CW; Tan JY; Wong WH; Cheong MA; Ng IM; Conceicao EP; Low JGH; Ng HJ; Lee LH
    Sci Rep; 2021 Jan; 11(1):1793. PubMed ID: 33469056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovaltry® and Jivi® Using CWA, Including sTF/7FIX Assay.
    Wada H; Shiraki K; Matsumoto T; Ohishi K; Shimpo H; Sakano Y; Nishii H; Shimaoka M
    Clin Appl Thromb Hemost; 2021; 27():1076029620976913. PubMed ID: 33606948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.